ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
A Prospect of Ranitidine Market Changes under the Expanding Influence of Genotoxic Impurities
April 22, 2020The U.S. FDA released the FDA Updates and Press Announcements on NDMA in Zantac (ranitidine) on April Fools’ Day to explain the change characteristics of the genotoxic impurities in ranitidine products and request all ranitidine manufacturers to remove su
Pharma Sources Insight January 2025
